Dr. Helen Kay Lester

DDS | Dentist



  
  2377 Oakmont Way, Eugene
  Oregon, 97401-6459

  541-686-2320    541-686-4110 Maps & Directions
Dr. Helen Kay Lester is a Eugene, Oregon based Dentist who is specialized in General Practice Dentistry. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 2377 Oakmont Way, Eugene. Patients can reach her at 541-686-2320.
Dr. Helen Kay Lester is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Helen Kay Lester speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Helen Kay Lester
Specialization: Dentist
Gender:Female
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:2377 Oakmont Way, Eugene,
Oregon, 97401-6459
Phone:541-686-2320
Fax:541-686-4110
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 0840258687
Enrollment ID: I20150723009447
NPI Number: 1154365096
NPI Enumeration Date: 15 Jun, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 2377 Oakmont Way,
Eugene, Oregon
Zip: 97401-6459
Phone Number: 541-686-2320
Fax Number: 541-686-4110
Patients can reach Dr. Helen Kay Lester at 2377 Oakmont Way, Eugene, Oregon or can call to book an appointment on 541-686-2320. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: